Lack of ISR / only 5% ISR in study with 656 samples [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2013-04-22 21:35 (4423 d 10:33 ago) – Posting: # 10462
Views: 15,029

Ahoy, my Capt’n, ahoy!

❝ sad story. I'd love to see the faces of the CMD(h) members if or when they realise that they have yet another ISR case to deal with. The details are good: the ISR seemed to work well in June, but NL's fear is it didn't in April?!?


That’s not a fear, but PSRPH… ISR ‘worked’ nicely in 5% of samples (in June), but 10% are “required” (published in August). Ha!

❝ […] and go ahead full throttle.


Do I look like James Dean?

❝ If any situation would merit a deviation from the guideline's requirement then this development would be a good candidate, wouldn't it.


I’m in the right mood for it. :-D

❝ Anyways to mitigate any risk, if this was a compound like meth (very -very!- low CV intra) …


Good guess. Not exactly meth (that was the story at the end of this post), but close. Remember the recent Two-Stage thread?

❝ … then you'd be looking at 12-16 subjects in a 222-BE trial. Would be a cheapo and could be done and dusted by any CRO way before the end of a clockstop.


Please no. BTW, at a meeting at the BfArM in 2010 they were surprised that we have done the MD study at all: “We expect that such a study will not be necessary any more according to the new MR GL.” Accumulation in the MD study was <1%…

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,678 registered users;
15 visitors (0 registered, 15 guests [including 13 identified bots]).
Forum time: 08:09 CEST (Europe/Vienna)

EMEA. The European Medicines Evaluation Agency.
The drug regulatory agency of the European Union.
A statistician-free zone.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5